Nomura Holdings’s scPharmaceuticals SCPH Stock Holding History

Nomura Holdings’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-103,200	Closed	-$585K	–	2134
2025 Q3	$585K	Hold	103,200	–	–	﹤0.01%	1560
2025 Q2	$393K	Buy	+103,200	New	+$320K	﹤0.01%	1181

Nomura Holdings's SCPH Position: Q4 2025 in Review

Nomura Holdings sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 736,041 shares — an estimated $4.17M sold.

Nomura Holdings first reported a position in SCPH in Q2 2025 and held it in 2 quarters. The position peaked at $4.17M in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

Nomura Holdings reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
Nomura Holdings sold 736,041 scPharmaceuticals shares in Q4 2025, an estimated $4.17M.
Nomura Holdings first reported a position in scPharmaceuticals in Q2 2025 and held it in 2 quarters.
Nomura Holdings's scPharmaceuticals position peaked at $4.17M in Q3 2025.
0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on Nomura Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.